TILRAY BRANDS INC (TLRY.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:TLRY • US88688T2096

10.43 CAD
-0.18 (-1.7%)
Last: Feb 4, 2026, 07:00 PM
Fundamental Rating

2

Taking everything into account, TLRY scores 2 out of 10 in our fundamental rating. TLRY was compared to 33 industry peers in the Pharmaceuticals industry. TLRY has a bad profitability rating. Also its financial health evaluation is rather negative. TLRY is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year TLRY has reported negative net income.
  • TLRY had a negative operating cash flow in the past year.
  • TLRY had negative earnings in each of the past 5 years.
  • In the past 5 years TLRY reported 4 times negative operating cash flow.
TLRY.CA Yearly Net Income VS EBIT VS OCF VS FCFTLRY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • With a Return On Assets value of -100.42%, TLRY is not doing good in the industry: 84.85% of the companies in the same industry are doing better.
  • TLRY's Return On Equity of -133.40% is on the low side compared to the rest of the industry. TLRY is outperformed by 75.76% of its industry peers.
Industry RankSector Rank
ROA -100.42%
ROE -133.4%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
TLRY.CA Yearly ROA, ROE, ROICTLRY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 -100 -200 -300

1.3 Margins

  • Looking at the Gross Margin, with a value of 28.02%, TLRY is in line with its industry, outperforming 42.42% of the companies in the same industry.
  • TLRY's Gross Margin has improved in the last couple of years.
  • TLRY does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
TLRY.CA Yearly Profit, Operating, Gross MarginsTLRY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100 -200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • TLRY does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • TLRY has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, TLRY has more shares outstanding
  • TLRY has a worse debt/assets ratio than last year.
TLRY.CA Yearly Shares OutstandingTLRY.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TLRY.CA Yearly Total Debt VS Total AssetsTLRY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

  • TLRY has an Altman-Z score of -1.67. This is a bad value and indicates that TLRY is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.67, TLRY is doing worse than 63.64% of the companies in the same industry.
  • A Debt/Equity ratio of 0.18 indicates that TLRY is not too dependend on debt financing.
  • TLRY's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. TLRY outperforms 60.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z -1.67
ROIC/WACCN/A
WACC8.37%
TLRY.CA Yearly LT Debt VS Equity VS FCFTLRY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.81 indicates that TLRY has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.81, TLRY is doing good in the industry, outperforming 69.70% of the companies in the same industry.
  • A Quick Ratio of 1.72 indicates that TLRY should not have too much problems paying its short term obligations.
  • TLRY has a better Quick ratio (1.72) than 78.79% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 1.72
TLRY.CA Yearly Current Assets VS Current LiabilitesTLRY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for TLRY have decreased strongly by -379.00% in the last year.
  • Looking at the last year, TLRY shows a small growth in Revenue. The Revenue has grown by 0.98% in the last year.
  • TLRY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 37.52% yearly.
EPS 1Y (TTM)-379%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59%
Revenue 1Y (TTM)0.98%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%3.11%

3.2 Future

  • TLRY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.45% yearly.
  • Based on estimates for the next years, TLRY will show a small growth in Revenue. The Revenue will grow by 4.41% on average per year.
EPS Next Y96.57%
EPS Next 2Y40.55%
EPS Next 3Y25.77%
EPS Next 5Y15.45%
Revenue Next Year3.9%
Revenue Next 2Y4.39%
Revenue Next 3Y4.03%
Revenue Next 5Y4.41%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TLRY.CA Yearly Revenue VS EstimatesTLRY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
TLRY.CA Yearly EPS VS EstimatesTLRY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5 -10 -15 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • TLRY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year TLRY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TLRY.CA Price Earnings VS Forward Price EarningsTLRY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as TLRY.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 21.35
TLRY.CA Per share dataTLRY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

  • TLRY's earnings are expected to grow with 25.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.55%
EPS Next 3Y25.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • TLRY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TILRAY BRANDS INC

TSX:TLRY (2/4/2026, 7:00:00 PM)

10.43

-0.18 (-1.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-08
Earnings (Next)04-06
Inst Owners11.21%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap1.21B
Revenue(TTM)837.32M
Net Income(TTM)-2.11B
Analysts71.25
Price Target19.17 (83.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.49%
Min EPS beat(2)-100.98%
Max EPS beat(2)100%
EPS beat(4)1
Avg EPS beat(4)-1374.81%
Min EPS beat(4)-5362.97%
Max EPS beat(4)100%
EPS beat(8)1
Avg EPS beat(8)-733.35%
EPS beat(12)2
Avg EPS beat(12)-748.47%
EPS beat(16)3
Avg EPS beat(16)-621.09%
Revenue beat(2)2
Avg Revenue beat(2)0.75%
Min Revenue beat(2)0.41%
Max Revenue beat(2)1.09%
Revenue beat(4)2
Avg Revenue beat(4)-4.75%
Min Revenue beat(4)-13.28%
Max Revenue beat(4)1.09%
Revenue beat(8)2
Avg Revenue beat(8)-5.24%
Revenue beat(12)3
Avg Revenue beat(12)-2.69%
Revenue beat(16)3
Avg Revenue beat(16)-3.19%
PT rev (1m)-18.79%
PT rev (3m)625.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-900%
EPS NY rev (1m)-1.84%
EPS NY rev (3m)-1114.12%
Revenue NQ rev (1m)0.38%
Revenue NQ rev (3m)0.38%
Revenue NY rev (1m)0.24%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.06
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB 1.1
EV/EBITDA 21.35
EPS(TTM)-19.62
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)-0.81
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS9.86
BVpS18.59
TBVpS9.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -100.42%
ROE -133.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.02%
FCFM N/A
ROA(3y)-48.32%
ROA(5y)-36.47%
ROE(3y)-65.2%
ROE(5y)-55.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.36%
GM growth 5YN/A
F-Score3
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA 7.07
Cap/Depr 40.31%
Cap/Sales 4.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 1.72
Altman-Z -1.67
F-Score3
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)21.23%
Cap/Depr(5y)65.01%
Cap/Sales(3y)3.68%
Cap/Sales(5y)7.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-379%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59%
EPS Next Y96.57%
EPS Next 2Y40.55%
EPS Next 3Y25.77%
EPS Next 5Y15.45%
Revenue 1Y (TTM)0.98%
Revenue growth 3Y9.34%
Revenue growth 5Y37.52%
Sales Q2Q%3.11%
Revenue Next Year3.9%
Revenue Next 2Y4.39%
Revenue Next 3Y4.03%
Revenue Next 5Y4.41%
EBIT growth 1Y41.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year109.23%
EBIT Next 3Y28.5%
EBIT Next 5Y17.38%
FCF growth 1Y-53.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.64%
OCF growth 3YN/A
OCF growth 5YN/A

TILRAY BRANDS INC / TLRY.CA FAQ

Can you provide the ChartMill fundamental rating for TILRAY BRANDS INC?

ChartMill assigns a fundamental rating of 2 / 10 to TLRY.CA.


What is the valuation status for TLRY stock?

ChartMill assigns a valuation rating of 1 / 10 to TILRAY BRANDS INC (TLRY.CA). This can be considered as Overvalued.


How profitable is TILRAY BRANDS INC (TLRY.CA) stock?

TILRAY BRANDS INC (TLRY.CA) has a profitability rating of 1 / 10.